A detailed history of Macquarie Group LTD transactions in Danaher Corp stock. As of the latest transaction made, Macquarie Group LTD holds 1,627,748 shares of DHR stock, worth $433 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares
1,627,748
Previous 1,618,508 0.57%
Holding current value
$433 Million
Previous $404 Million 0.62%
% of portfolio
0.48%
Previous 0.46%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$235.51 - $267.98 $2.18 Million - $2.48 Million
9,240 Added 0.57%
1,627,748 $407 Million
Q1 2024

May 14, 2024

SELL
$224.58 - $256.19 $667,002 - $760,884
-2,970 Reduced 0.18%
1,618,508 $404 Million
Q4 2023

Feb 14, 2024

BUY
$185.1 - $233.13 $3.35 Million - $4.22 Million
18,120 Added 1.13%
1,621,478 $375 Million
Q3 2023

Nov 14, 2023

SELL
$233.08 - $265.59 $72.3 Million - $82.3 Million
-310,059 Reduced 16.2%
1,603,358 $398 Million
Q2 2023

Aug 14, 2023

BUY
$224.99 - $256.14 $35.8 Million - $40.7 Million
158,910 Added 9.06%
1,913,417 $459 Million
Q1 2023

May 15, 2023

BUY
$239.75 - $277.0 $76.7 Million - $88.6 Million
319,974 Added 22.31%
1,754,507 $442 Million
Q4 2022

Feb 21, 2023

BUY
$241.42 - $282.29 $105 Million - $123 Million
436,073 Added 43.67%
1,434,533 $381 Million
Q3 2022

Nov 14, 2022

SELL
$247.06 - $1507.4 $13.8 Million - $84.2 Million
-55,832 Reduced 5.3%
998,460 $258 Million
Q2 2022

Aug 15, 2022

SELL
$237.11 - $299.66 $11.4 Million - $14.4 Million
-47,940 Reduced 4.35%
1,054,292 $267 Million
Q1 2022

May 16, 2022

BUY
$257.27 - $315.76 $7.44 Million - $9.13 Million
28,925 Added 2.69%
1,102,232 $323 Million
Q4 2021

Feb 11, 2022

BUY
$292.08 - $329.01 $95.9 Million - $108 Million
328,202 Added 44.05%
1,073,307 $353 Million
Q3 2021

Nov 12, 2021

SELL
$272.21 - $332.43 $5.42 Million - $6.62 Million
-19,913 Reduced 2.6%
745,105 $227 Million
Q2 2021

Aug 13, 2021

BUY
$225.08 - $271.69 $154 Million - $186 Million
683,791 Added 841.83%
765,018 $205 Million
Q1 2021

May 14, 2021

SELL
$212.38 - $245.9 $1.35 Million - $1.56 Million
-6,338 Reduced 7.24%
81,227 $18.3 Million
Q4 2020

Feb 16, 2021

SELL
$212.5 - $245.46 $1.45 Million - $1.68 Million
-6,844 Reduced 7.25%
87,565 $19.5 Million
Q3 2020

Nov 13, 2020

BUY
$177.16 - $215.33 $284,696 - $346,035
1,607 Added 1.73%
94,409 $20.3 Million
Q2 2020

Aug 11, 2020

SELL
$128.7 - $176.83 $1.1 Million - $1.5 Million
-8,509 Reduced 8.4%
92,802 $16.4 Million
Q1 2020

May 15, 2020

SELL
$121.39 - $169.05 $2.24 Million - $3.12 Million
-18,452 Reduced 15.41%
101,311 $14 Million
Q4 2019

Feb 14, 2020

SELL
$133.47 - $153.48 $7.05 Million - $8.1 Million
-52,785 Reduced 30.59%
119,763 $18.4 Million
Q3 2019

Nov 14, 2019

BUY
$135.4 - $146.47 $64,044 - $69,280
473 Added 0.27%
172,548 $24.9 Million
Q2 2019

Aug 14, 2019

SELL
$124.88 - $143.73 $2.1 Million - $2.42 Million
-16,838 Reduced 8.91%
172,075 $24.6 Million
Q1 2019

May 15, 2019

BUY
$97.62 - $132.29 $210,566 - $285,349
2,157 Added 1.15%
188,913 $24.9 Million
Q4 2018

Feb 15, 2019

BUY
$94.85 - $109.54 $20,677 - $23,879
218 Added 0.12%
186,756 $19.3 Million
Q3 2018

Nov 15, 2018

SELL
$98.13 - $108.9 $3.4 Million - $3.78 Million
-34,695 Reduced 15.68%
186,538 $20.3 Million
Q2 2018

Aug 14, 2018

BUY
$96.1 - $103.24 $952,447 - $1.02 Million
9,911 Added 4.69%
221,233 $21.8 Million
Q1 2018

May 11, 2018

SELL
$92.16 - $103.8 $1.42 Million - $1.6 Million
-15,410 Reduced 6.8%
211,322 $20.7 Million
Q4 2017

Feb 15, 2018

SELL
$85.26 - $94.62 $7.15 Million - $7.94 Million
-83,886 Reduced 27.01%
226,732 $21.1 Million
Q3 2017

Nov 08, 2017

BUY
$79.29 - $88.45 $24.6 Million - $27.5 Million
310,618
310,618 $26.6 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $194B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.